Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-08-21
1998-10-06
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514391, 5483171, 5483205, 5483211, A61K 31415, C07D23374
Patent
active
058176853
ABSTRACT:
Anticonvulsive compounds and compositions, of the formula ##STR1## in which X is a C.sub.1-4 -alkyl, trifluoromethyl, or halogen residue, Y is hydrogen or halogen, n is 0 or 1, and m is 0 or a cardinal number from 1 to 4, and its pharmacologically acceptable acid addition salts.
REFERENCES:
patent: 5545652 (1996-08-01), Itoh et al.
Idi et al, "A Carbon--13NMR Study of, etc" CA 85:191674, 1976.
Waser et al, "Development of New Antiepileptic Drugs, etc" CA 88:69084, 1978.
H.E. Zaugg and D.L. Arendsen-Synthesis of Fused Hydantoins by Intramolecular Amidolkylation pp. 803-806 (1974).
Harvey J. Kupferberg--Strategies for identifying and developing new anticonsulvant drugs. pp. 132-138 (1992).
Lankau Hans-Joachim
Menzer Manfred
Rostock Angelika
Unverferth Klaus
Arzneimittelwerk Dresden GmbH
Morris Patricia L.
LandOfFree
Anticonvulsive imidazoline-2,4-diones and process for making does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anticonvulsive imidazoline-2,4-diones and process for making, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anticonvulsive imidazoline-2,4-diones and process for making will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-77649